메인콘텐츠 바로가기 메뉴영역 바로가기
하이로닉 로고

하이로닉 인터내셔널 웹사이트로 이동합니다.
인터내셔널 웹사이트에는 수출용 제품으로 대한민국에서 허가하지 않은 장비 및 서비스 내용을 포함하고 있습니다. 해당 내용은 대한민국의 의료기기 광고 심의, 규제를 받지 않습니다.

인터내셔널 웹사이트 →

It goes to the HIRONIC INTL. website.
The Intrrnation Web Site contains equipment and services that are not authorized by the Republic of Korea These contents are not subject to review and regulation of medical devices in Korea.

International Website →
닫기
하이로닉 로고

하이로닉 US 웹사이트로 이동합니다.
US 웹사이트의 내용은 "FDA"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

US 웹사이트 →

It goes to the HIRONIC US website.
The contents of the US web page are about product information of items approved for "FDA". They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

US Website →
닫기
하이로닉 로고

하이로닉 EU 웹사이트로 이동합니다.
EU 웹사이트의 내용은 "CE MDD 또는 CE MDR"로 부터 허가승인된 품목의 제품 정보에 관한 것으로, 대한민국의 소비자 보호를 위한 국내법 의료기기의 광고 심의, 규제를 받지 않습니다.

EU 웹사이트 →

It goes to the HIRONIC EU website.
The contents of the EU(European) web page are about product information of items approved for "CEMDD or CEMDR" in EU countries. They are not subject to advertising deliberation and regulation of domestic law medical devices for consumer protection in Korea.

EU Website →
닫기
NEWS

총 242개의 게시물이 있습니다.

NEWS 목록 : 번호, 제목, 첨부, 작성일, 조회로 구성
HIRONIC has been featured in the November/December issue of The Aesthetic Guide!Under the theme "Device with Synergistic Technologies Customizes Treatment from Skin to SMAS,"  The aesthetic guide highlighted our New Dublo 2.0™ as innovative device performing revolutionary treatment.Our esteemed Dr. Hanwon Ryu and Dr. Kyuhong Hwang shared insights into the diverse features and synergistic lifting technologies of the New Doublo 2.0.Discover proven results and expert insights in this latest edition. 
2024-12-10
HIRONIC Unveils the Latest in HIFU Technology with New Doublo 2.0 at Taiwanese Dermatological MeetingTaipei, November 16, 2024  HIRONIC, a leader in medical aesthetic technology, introduced the groundbreaking New Doublo 2.0, featuring integrated Radio Frequency (RF), at the 50th Annual Meeting of the Taiwanese Dermatological Association held at the Taipei International Convention Center.The latest iteration of the popular Doublo series, the New Doublo 2.0, represents a significant advancement in High-Intensity Focused Ultrasound (HIFU) technology. Dr. Hanwon Ryu, a renowned expert in dermatological innovations, led the session titled "Breaking the Boundaries of HIFU: Introducing New Doublo 2.0 with RF for Comprehensive Multilayer Lifting – From Epidermis to SMAS."During his presentation, Dr. Ryu elaborated on the enhanced capabilities of the New Doublo 2.0, which now combines traditional HIFU with RF technology to provide a more comprehensive and effective treatment. The integrated RF module targets the epidermal and dermal layers of the skin, while the HIFU technology reaches deeper into the subcutaneous tissue and SMAS (Superficial Muscular Aponeurotic System), offering a multilayer lifting effect."This combination allows for precise and controlled skin lifting and tightening, effectively addressing the needs of patients looking for non-invasive rejuvenation treatments," explained Dr. Ryu. The New Doublo 2.0 also boasts improved patient comfort and shorter treatment times, making it a compelling choice for both practitioners and clients.The unveiling of the New Doublo 2.0 was met with positive reception from dermatologists and medical professionals attending the conference, further cementing HIRONIC's position at the forefront of innovative aesthetic solutions.​ 
2024-12-10
HIRONIC Co., Ltd. announced that its innovative plasma device, Plasonic, has received FDA approval from the U.S. Food and Drug Administration. This marks HIRONIC’s second FDA approval following the certification of Silkro, further establishing the company's reputation for safe and effective skin aesthetic medical technology.Plasonic harnesses plasma, known as the fourth state of matter (beyond solid, liquid, and gas), which is a naturally occurring ionized energy often observed in natural phenomena. Renowned for its sterilization and regenerative properties, plasma-based skin treatments have already become mainstream across Europe.Plasonic combines two mechanisms—plasma and ultrasound—to maximize the absorption of cosmetic or skin booster ingredients. Plasma ions create a membrane potential effect on the skin, creating microchannels between skin cells, allowing ingredients to penetrate deeply and enhance the skin’s absorption, promoting aesthetic improvements. Equipped with the Plapass (plasma) and Sonopass (ultrasound) handpieces, Plasonic delivers precise and effective treatments that remove skin lesions with minimal damage, ensuring safe procedures. In tests conducted by the Korean Dermatology Research Institute, skin treated with Plasonic’s plasma showed 4.66 times greater permeability than untreated skin, validating the role of ultrasound in enhancing the penetration of active ingredients.A HIRONIC spokesperson stated, “FDA approval for Plasonic will enable HIRONIC to distinguish itself in the global skin booster market, including the United States. With this recognition of our innovative technology and safety, we are committed to providing North American customers with advanced aesthetic medical technology that guarantees both innovation and safety.”The global skin booster market, valued at $1 billion in 2022, is projected to grow at an annual rate of 10%, reaching an estimated $2.1 billion by 2030. Currently, injectables dominate over 90% of the skin booster market, but the EBD (Energy-Based Device) sector is expanding rapidly. Given the significant growth in the U.S. medspa market, HIRONIC’s FDA approval paves the way for substantial achievements in the U.S. market.​
2024-11-11
The 19th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     
2024-11-05
We are excited to announce HIRONIC’s participation in two major events this November, where our esteemed doctors will present pioneering advancements in medical aesthetics, featuring our latest technologies, the New Doublo 2.0™ and PICOHI™. <Vietnam Grand Launching>Date: 10th November 2024Venue: New World Saigon Hotel, Ho Chi Minh City, VietnamJoin us for an insightful day with our key experts:Dr. Wonkyu HongOptimal Skin Rejuvenation with New TechnologyAn exploration of the synergy between MFU Dotting and RF technology for enhanced skin rejuvenation.Dr. Thitikom LimrattanamekhaMulti-Treatment of Acne Scars in PracticeDiscover practical approaches to effectively address acne scars using our advanced methods.Dr. Jiehoon KimPicosecond Laser in Pigmentation Treatment and Skin RejuvenationAn in-depth look at the efficacy of a 300ps pulse duration laser in rejuvenating skin and treating pigmentation disorders in Asian skin types.<50th Annual Meeting of Taiwanese Dermatological Association>Date: 16th November 2024Venue: Taipei International Convention Center (TICC), Taipei, TaiwanAt this esteemed gathering, our distinguished doctors will also share:Dr. Hanwon RyuBreaking the Boundaries of HIFU: Introducing Doublo 2.0 with RF for Comprehensive Multilayer LiftingLearn about our innovative approach to lifting from the epidermis down to the SMAS layer. We invite you to experience the latest innovations in dermatological treatments and engage with leading experts in the field. Our team will be on hand to discuss how these groundbreaking technologies can elevate your practice and answer any inquiries you may have.​ 
2024-11-05
The HIRONIC Distributor Training program is back for its November schedule!Enrollment is now open, and we invite all our international distribution partners to join us in this comprehensive educational initiative.  As a leading manufacturer of cutting-edge skincare solutions, we recognize the crucial role our distributors play in delivering our products to customers worldwide.  This training program aims to empower your sales and marketing teams with the knowledge and skills necessary to effectively represent the HIRONIC brand and drive successful market penetration in your respective regions.  Our expert instructors will guide you through interactive sessions, hands-on demonstrations, and case studies.   
2024-11-05
​On the evening of October 14, 2024, HIRONIC celebrated the grand launch of New Doublo 2.0 and PICOHI devices in collaboration with Optima Aesthetic at the Park Hyatt Bangkok’s Grand Ballroom. The event, attended by industry leaders and healthcare professionals, marked a significant milestone in HIRONIC's commitment to advancing medical aesthetics in Thailand.The launch was met with overwhelming interest from local stakeholders, reflecting the strong growth potential of the aesthetic medicine sector in Thailand. New Doublo 2.0, known for its precision and effectiveness, along with the innovative PICOHI, received enthusiastic reception, illustrating the demand for cutting-edge technologies in the local market.Throughout the night, attendees engaged in meaningful discussions, exploring the implications of these new technologies for their practices. The successful introduction of these devices has set the stage for their adoption across various clinics throughout Thailand, signaling a promising future for both HIRONIC and the Thai aesthetics industry.As we move forward, HIRONIC anticipates a fruitful partnership with Optima Aesthetic and looks forward to contributing to the dynamic growth of aesthetic medicine in Thailand.   
2024-10-17
The 18th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!    
2024-10-02
New Doublo 2.0™  presented at BODY ON TOP 2024.The live demonstration and hands-on workshop provided a practical insight into the 4th Generation HIFU + RF technology, highlighting its pain-free and swift treatment capabilities. We received lots of positive feedback from the doctors present, particularly impressed with the speed of treatment and the absence of pain during application. 
2024-10-02
HIRONIC is excited to announce that our premier medical device, NEW DOUBLO 2.0, has successfully obtained medical device certification from Argentina's National Administration of Drugs, Food and Medical Technology (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica).This achievement opens significant opportunities for us to expand into the Argentine market, which boasts considerable economic potential. Argentina is anticipated to continue its steady economic growth in the coming years. These factors are expected to drive an increasing demand for medical services, creating an ideal environment for introducing our advanced medical solutions.We are thrilled to bring NEW DOUBLO 2.0 to such a dynamic and growing market, and we are committed to increasing our presence across South America, enhancing beautycare outcomes with our innovative technology.  
2024-10-02
HIRONIC is committed to supporting our partners comprehensively. Recently, our team visited Vietnam to conduct hands-on training sessions with our most popular devices, the New Doublo 2.0 and Doublo Gold.   Over a two-day period, our trainers delivered one-on-one technical training and clinical education, sharing protocols and treatment expertise to ensure proficient use of our equipment.   Our dedicated Business Development team provides personalized communications about your products to ensure you achieve success through our support. We encourage you to take full advantage of the best-in-class training and educational opportunities included in our partnership.  ​
2024-09-27
The 17th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     
2024-09-06
HIRONIC has obtained approval from the Thai Food and Drug Administration (TFDA) on the 2nd of this month for its New Doublo2.0, a cutting-edge lifting device that incorporates both HIFU (MFU) and RF technologies. This device, equipped with advanced safety features, has already reached over 20 countries worldwide.The approval of New Doublo2.0 marks a significant step in strengthening HIRONIC's competitive edge in Thailand's medical aesthetics market. We are focused on expanding our sales and marketing efforts across Thailand and other Asian markets. Plans are underway to effectively communicate the product's capabilities through various initiatives targeted at local medical institutions and aesthetic professionals (key opinion leaders).These initiatives include exhibitions, academic programs, and hands-on training sessions. We also plan to continuously enhance the synergy between our upcoming new products by leveraging our high brand recognition and extensive local distribution networks.HIRONIC plans to further expand its sales and marketing initiatives to continue its leading position in Thailand, a major hub for beauty and cosmetic in Southeast Asia.​ 
2024-09-04
The 16th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     
2024-08-14
Dear Esteemed Key Opinion Leaders and Doctors,We are thrilled to announce an exclusive event.Join us on the 23rd of October for our BIG LAUNCH EVENT in Brazil. This gathering promises to be a landmark occasion, showcasing groundbreaking innovations and offering networking opportunities.We can't wait to unveil what we've been working on. Stay tuned for more details and get ready to be inspired!  
2024-08-14